Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?

Published on 17 Dec 2024 on Benzinga · via Yahoo Finance

On Tuesday, Biomea Fusion Inc. (NASDAQ:BMEA) revealed topline results from the ongoing COVALENT-111...

Read the rest of the article

Start tracking your investments with Statfolio

On Tuesday, Biomea Fusion Inc. (NASDAQ:BMEA) revealed topline results from the ongoing COVALENT-1...

Benzinga · via Yahoo Finance 17 Dec 2024

Even if it's not a huge purchase, we think it was good to see that Franco Valle, the CFO & Princi...

Simply Wall St. · via Yahoo Finance 18 Jun 2024

We recently compiled a list of What Is Short Selling In Stock Market? 15 Stocks Hedge Funds are S...

Insider Monkey · via Yahoo Finance 18 Jun 2024

We recently compiled the list of the Analysts on Wall Street Lower Ratings for These 10 Stocks. I...

Insider Monkey · via Yahoo Finance 18 Jun 2024

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Biomea Fusion, Inc. BMEA, a clinical-stage company, is focused on the discovery and development o...

Zacks via Yahoo Finance 12 Dec 2023

Biomea Fusion, Inc. BMEA, a clinical-stage company, announced dosing the first patient in its ear...

Zacks via Yahoo Finance 18 Oct 2023

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 5 Oct 2023

Biomea Fusion Inc (NASDAQ: BMEA) announced the presentation of new clinical data from the first t...

Benzinga via Yahoo Finance 26 Jun 2023

Shares of Biomea Fusion Inc. jumped 17% in premarket trading Monday after the clinical-stage biop...

Market Watch 26 Jun 2023